Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ayala Pharmaceuticals Inc (AYLA)
NASDAQ:AYLA
RESEARCH TOOLSreports
Ayala Pharmaceuticals (AYLA) Financial Statements
0 Followers
Ayala Pharmaceuticals Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 91.00K | $ 38.00K | $ 458.00K | $ 1.15M | $ 625.00K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 90.00K | $ 0.00 | $ 0.00 |
| EBIT | $ -10.08M | $ -7.84M | $ -9.85M | $ -9.77M | $ -9.57M |
| EBITDA | $ -10.04M | $ -7.79M | $ -9.82M | $ -9.74M | $ -9.52M |
| Net Income Common Stockholders | $ -10.19M | $ -8.21M | $ -10.03M | $ -10.05M | $ -9.80M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 11.20M | $ 20.06M | $ 27.05M | $ 36.98M | $ 40.84M |
| Total Assets | $ 14.26M | $ 24.02M | $ 30.65M | $ 41.13M | $ 45.74M |
| Total Debt | $ 396.00K | $ 414.00K | $ 472.00K | $ 497.00K | $ 493.00K |
| Net Debt | $ -10.80M | $ -19.64M | $ -26.58M | $ -36.48M | $ -40.35M |
| Total Liabilities | $ 6.10M | $ 6.66M | $ 5.83M | $ 6.97M | $ 6.36M |
| Stockholders Equity | $ 8.16M | $ 17.36M | $ 24.82M | $ 34.16M | $ 39.38M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -9.34M | $ -7.02M | $ -9.98M | $ -7.79M | $ -9.37M |
| Operating Cash Flow | $ -9.34M | $ -7.02M | $ -9.98M | $ -7.79M | $ -9.37M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -2.00K |
| Financing Cash Flow | $ 468.00K | $ 0.00 | $ 44.00K | $ 3.95M | $ 5.80M |
Ayala Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.